ALK and pancreatic ductal adenocarcinoma: Herein, we firstly presented a case about pancreatic ductal adenocarcinoma patient concurrent to targetable rare somatic novel KANK1-ALK, UPP2-NTRK3 fusion, and pathogenetic germline BRCA mutation.